Literature DB >> 15677828

Possible beneficial effect of telmisartan on glycemic control in diabetic subjects.

Sachiko Honjo, Yuichi Nichi, Yoshiharu Wada, Yoshiyuki Hamamoto, Hiroyuki Koshiyama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15677828     DOI： 10.2337/diacare.28.2.498

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  6 in total

1.  Relationship between telmisartan dose and glycaemic control in Japanese patients with type 2 diabetes mellitus and hypertension: a retrospective study.

Authors:  Yoshiyuki Hamamoto; Sachiko Honjo; Yukiko Kawasaki; Hiroki Ikeda; Kanako Mori; Kanta Fujimoto; Hisato Tatsuoka; Yorihiro Iwasaki; Kazuhiro Nomura; Yoshiharu Wada; Hiroki Koshiyama
Journal:  Clin Drug Investig       Date:  2012-09-01       Impact factor: 2.859

Review 2.  New standards in hypertension and cardiovascular risk management: focus on telmisartan.

Authors:  Domenico Galzerano; Cristina Capogrosso; Sara Di Michele; Antonio Galzerano; Paola Paparello; Diana Lama; Carlo Gaudio
Journal:  Vasc Health Risk Manag       Date:  2010-03-24

3.  Four novel UCP3 gene variants associated with childhood obesity: effect on fatty acid oxidation and on prevention of triglyceride storage.

Authors:  C V Musa; A Mancini; A Alfieri; G Labruna; G Valerio; A Franzese; F Pasanisi; M R Licenziati; L Sacchetti; P Buono
Journal:  Int J Obes (Lond)       Date:  2011-04-19       Impact factor: 5.095

4.  Effects of ACE inhibitors on insulin resistance and lipid profile in children with metabolic syndrome.

Authors:  Eda Celebi Bitkin; Mehmet Boyraz; Necati Taşkın; Arzu Akçay; Korkut Ulucan; Mehmet Bedir Akyol; Teoman Akçay
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013-09-10

5.  Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway.

Authors:  Xiurong Li; Yuhuai Lan; Yan Wang; Minghao Nie; Yanhong Lu; Eryang Zhao
Journal:  Mol Med Rep       Date:  2017-03-14       Impact factor: 2.952

6.  Rosmarinic acid monotherapy is better than the combination of rosmarinic acid and telmisartan in preventing podocyte detachment and inhibiting the progression of diabetic nephropathy in rats.

Authors:  Nur Samsu; Setyawati Soeharto; Muhaimin Rifai; Achmad Rudijanto
Journal:  Biologics       Date:  2019-08-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.